Pediatrix Medical Group, the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty physician services, announced cut of its second-quarter and full-year expectations that resulted in sharp decrease of its stock.
Pediatrix shares dropped $5.64, or more than 10 percent, to $49.79, in morning trading.
The company reported that first six weeks of the second quarter showed tangible decline of neonatal intensive-care unit patients.
As a result it predicts second-quarter earnings of between 77 and 80 cents per share, in comparison to previous expectations of 85 to 87 cents per share. The company highlighted that it may miss full-year profit estimates of between $3.35 and $3.45 per share.
Pediatrix focuses on improving patient care and participate in ongoing research and quality improvement programs to enhance outcomes nationwide. Pediatrix is also one of the nation's largest providers of newborn hearing and metabolic screens.
The behavior of the Russian inspector satellite, which was launched in the autumn of 2017, puzzles military officials in the United States
Ukrainian bloggers draw a parallel between the events in East Timor and the Crimea. Any comparison has a right to exist, but a detailed analysis of the situation does not give a promising forecast to Ukraine
Vladimir Putin is planning to attend the wedding ceremony of Austria's Foreign Minister Karin Kneissl on the way to Berlin